Offer members evidence about medical technologies

Article

It's not uncommon for bias and inaccuracies to infiltrate consumer health information and influence members' opinions about the healthcare they receive

With the array of new health technologies clamoring for attention from consumers and providers, the impact on managed care organizations can be significant as the costs associated with making wrong decisions continue to escalate. New and emerging technologies, even those approved for marketing, often have a limited evidence base with regard to their relative effectiveness and impact on clinical outcomes. Some are no more effective than competing technologies already in widespread clinical use; many are more expensive than existing options. Likewise, serious and life-threatening safety issues often don't emerge until after a new technology has been used by large numbers of patients over a longer period of time.

Related Videos
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 2 - "Addressing Coexisting Conditions: Keys to Comprehensive Diabetes Care"
Related Content
© 2024 MJH Life Sciences

All rights reserved.